Stryker announces takeover of Entellus Medical

Stryker has announced the acquisition of Entellus Medical, a high-growth global medical technology company based in Minnesota.

The firm is focused on the development of products designed for the minimally invasive treatment of various ear, nose and throat (ENT) diseases, including the XprESS Multi-Sinus Dilation System and the Latera Absorbable Nasal Implant.

Stryker expects the $662 million (492.82 million pounds) deal will be highly complementary to the existing ENT portfolio of its instruments business.

Timothy Scannell, president for Stryker's MedSurg and neurotechnology group, said: "Entellus is a leader in the ENT segment and offers a comprehensive portfolio of products that enable physicians to conveniently and comfortably perform a broad range of ENT procedures."

This comes after Stryker last month agreed a deal to acquire Vexim, a French medical device company headquartered in Balma. The business specialises in the development and sale of vertebral compression fracture solutions, including its flagship offering SpineJack.

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.